• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用血浆中段心房利钠肽测量值评分来估计心房颤动持续时间。

Score Using Measurements of Plasma Midregional Pro-Atrial Natriuretic Peptide to Estimate the Duration of Atrial Fibrillation.

作者信息

Legallois Damien, Sorbets Emmanuel, Chenevier-Gobeaux Camille, Hallouche Maya, Boubaya Marouane, Charnaux Nathalie, Lebon Alain, Levy Vincent, Beygui Farzin, Meune Christophe

机构信息

Cardiology Department, Caen University Hospital, Caen, France.

Cardiology Department, FACT (French Alliance for Cardiovascular Trials), Avicenne and Bichat Hospital, Bobigny, France.

出版信息

J Appl Lab Med. 2017 Mar 1;1(5):522-531. doi: 10.1373/jalm.2016.021477.

DOI:10.1373/jalm.2016.021477
PMID:33379800
Abstract

BACKGROUND

An accurate estimate of the duration of atrial fibrillation (AF) is critical for its safe and successful management. We examined the ability of midregional pro-atrial natriuretic peptide (MR-proANP) to identify patients presenting with AF of ≤48 vs >48 h in duration.

METHODS

We prospectively studied 106 patients presenting with AF of known duration. We examined the predictive values of MR-proANP and N-terminal pro-brain natriuretic peptide (NT-proBNP) in the detection of recent-onset AF, in addition to other factors identified by multiple variable analyses.

RESULTS

In patients presenting with AF of ≤48 vs >48 h in duration, the median MR-proANP plasma concentration was 147.7 [95.3-197.4] pmol/L vs 220.4 [154.0-303.1] pmol/L (P <0.001). MR-proANP and NT-proBNP were correlated (r = 0.5, P <10-7), but MR-proANP tended to better discriminate AF of ≤48 h in duration than NT-proBNP (P = 0.09). A score including heart rate, dyspnea, and MR-proANP concentration accurately detected AF of ≤48 h in duration (area under the curve = 0.890; 95% CI, 0.828-0.952). A score of 98 points was an optimal cutoff that excluded AF of ≤48 h in duration with a sensitivity of 95%, while a score of 132.5 points was an optimal cutoff that confirmed AF of ≤48 h in duration with a sensitivity of 95%. Overall, a score ≤98 or ≥132.5 identified AF of ≤48 h in duration in 56% of patients.

CONCLUSIONS

A score based on a model including heart rate, dyspnea, and plasma MR-proANP concentration was helpful in identifying AF of ≤48 h in duration.

摘要

背景

准确估计房颤(AF)的持续时间对其安全、成功管理至关重要。我们研究了中段心房利钠肽前体(MR-proANP)识别房颤持续时间≤48小时与>48小时患者的能力。

方法

我们前瞻性研究了106例已知房颤持续时间的患者。除多变量分析确定的其他因素外,我们还研究了MR-proANP和N末端脑利钠肽前体(NT-proBNP)在检测近期发作房颤中的预测价值。

结果

房颤持续时间≤48小时与>48小时的患者相比,MR-proANP血浆浓度中位数分别为147.7[95.3 - 197.4]pmol/L和220.4[154.0 - 303.1]pmol/L(P<0.001)。MR-proANP与NT-proBNP相关(r = 0.5,P<10-7),但MR-proANP在区分持续时间≤48小时的房颤方面往往比NT-proBNP更好(P = 0.09)。一个包含心率、呼吸困难和MR-proANP浓度的评分能准确检测出持续时间≤48小时的房颤(曲线下面积 = 0.890;95%CI,0.828 - 0.952)。98分是排除持续时间≤48小时房颤的最佳截断值,敏感性为95%,而132.5分是确诊持续时间≤48小时房颤的最佳截断值,敏感性为95%。总体而言,评分≤98或≥132.5可在56%的患者中识别出持续时间≤48小时的房颤。

结论

基于心率、呼吸困难和血浆MR-proANP浓度的模型评分有助于识别持续时间≤48小时的房颤。

相似文献

1
Score Using Measurements of Plasma Midregional Pro-Atrial Natriuretic Peptide to Estimate the Duration of Atrial Fibrillation.利用血浆中段心房利钠肽测量值评分来估计心房颤动持续时间。
J Appl Lab Med. 2017 Mar 1;1(5):522-531. doi: 10.1373/jalm.2016.021477.
2
Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.比较 mid-regional pro-atrial natriuretic peptide 与 N-terminal pro B-type natriuretic peptide 在诊断心房颤动伴呼吸困难患者中的作用。
Heart. 2012 Oct;98(20):1518-22. doi: 10.1136/heartjnl-2012-302260. Epub 2012 Aug 3.
3
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.比较中段心房利钠肽原与N末端B型利钠肽原在预测慢性心力衰竭患者生存率中的作用
J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. doi: 10.1016/j.jacc.2007.08.012. Epub 2007 Oct 29.
4
Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.用于诊断呼吸急促患者急性失代偿性心力衰竭的中段心房利钠肽前体测量:与B型利钠肽(BNP)和氨基末端脑钠肽前体的比较
Clin Chem. 2006 May;52(5):827-31. doi: 10.1373/clinchem.2005.065441. Epub 2006 Mar 16.
5
Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial).利钠肽作为心房颤动负荷和复发的标志物(来自AMIO-CAT试验)
Am J Cardiol. 2017 Oct 15;120(8):1309-1315. doi: 10.1016/j.amjcard.2017.07.018. Epub 2017 Jul 24.
6
Natriuretic Peptides to Classify Risk of Atrial Fibrillation Detection After Stroke: Analysis of the BIOSIGNAL and PRECISE Cohort Studies.利钠肽对卒中后心房颤动检测风险的分类作用:BIOSIGNAL 和 PRECISE 队列研究分析。
Neurology. 2024 Aug 13;103(3):e209625. doi: 10.1212/WNL.0000000000209625. Epub 2024 Jul 1.
7
Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.中段心房利钠肽原是检测冠心病患者左心室功能受损的有用指标。
Int J Cardiol. 2008 Aug 18;128(2):244-9. doi: 10.1016/j.ijcard.2007.04.113. Epub 2007 Jul 27.
8
Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.中段心房利钠肽在急诊根据肾功能诊断与心脏相关的呼吸困难中的应用:与 B 型利钠肽(BNP)和 N 末端 proBNP 的比较。
Clin Chem. 2010 Nov;56(11):1708-17. doi: 10.1373/clinchem.2010.145417. Epub 2010 Sep 2.
9
Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.血浆N末端B型利钠肽作为急性心肌梗死后长期生存的指标:与血浆中段心房利钠肽的比较:LAMP(莱斯特急性心肌梗死肽)研究
J Am Coll Cardiol. 2008 May 13;51(19):1857-64. doi: 10.1016/j.jacc.2008.01.041.
10
Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.NT-proANP 和 NT-proBNP 在心房颤动患者中的作用:与心房颤动进展表型的关系。
Heart Rhythm. 2018 Aug;15(8):1132-1137. doi: 10.1016/j.hrthm.2018.03.021. Epub 2018 Mar 29.

引用本文的文献

1
How to Use Natriuretic Peptides in Patients with Heart Failure with Non-Reduced Ejection Fraction?心力衰竭伴射血分数未降低患者如何使用利钠肽?
Anatol J Cardiol. 2023 Jun;27(6):308-318. doi: 10.14744/AnatolJCardiol.2023.3297.
2
Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP - A narrative review.心房颤动、血栓栓塞风险与利钠肽的潜在作用,聚焦于脑钠肽和N末端脑钠肽原——一篇叙述性综述
Int J Cardiol Heart Vasc. 2022 Oct 10;43:101132. doi: 10.1016/j.ijcha.2022.101132. eCollection 2022 Dec.
3
Relationship of Natriuretic Peptides with Left Atrial Structure and Function within 1 Month after Electrical Cardioversion in Patients with Persistent Atrial Fibrillation.
电复律后 1 个月内持续性心房颤动患者心钠肽与左心房结构和功能的关系。
Biomed Res Int. 2019 Mar 17;2019:7636195. doi: 10.1155/2019/7636195. eCollection 2019.